NASDAQ
Eiger BioPharmaceuticals, Inc. (EIGRQ) has a revenue compound annual growth rate of . Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.